Luisa Hector
Stock Analyst at Berenberg Bank
(3.82)
# 1,969
Out of 4,587 analysts
291
Total ratings
60.7%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by Luisa Hector
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | 12,720p | +25.79% | 71 | Jul 27, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €105.00 | €72.77 | +44.29% | 51 | Jul 22, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $115 → $125 | $129.79 | -3.69% | 34 | Jun 22, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $257.41 | +6.83% | 18 | May 8, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | CHF 353.40 | -3.79% | 52 | May 8, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 92.00 → CHF 110.00 | CHF 126.78 | -13.24% | 4 | Mar 6, 2026 | |
| LON: BTRW Barratt Redrow plc | Maintained: Hold | 414p | 295p | +40.29% | 1 | Feb 11, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Buy | kr 400.00 → kr 415.00 | kr 335.80 | +23.59% | 7 | Jan 16, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | 1,660p | 1,940p | -14.43% | 7 | Jan 6, 2026 | |
| SNY Sanofi | Maintained: Buy | $63 → $67 | $42.89 | n/a | 11 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $60 | $64.86 | n/a | 18 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €197.00 | €142.85 | n/a | 13 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 | $24.91 | n/a | 1 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €78.58 | €48.44 | n/a | 1 | Sep 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.97 | n/a | 2 | Sep 15, 2016 |
AstraZeneca PLC
Jul 27, 2026
Maintained: Buy
Price Target: 16,000p
Current: 12,720p
Upside: +25.79%
Sanofi
Jul 22, 2026
Maintained: Buy
Price Target: €105.00
Current: €72.77
Upside: +44.29%
Merck & Co.
Jun 22, 2026
Maintained: Hold
Price Target: $115 → $125
Current: $129.79
Upside: -3.69%
AbbVie
May 8, 2026
Maintained: Buy
Price Target: $275
Current: $257.41
Upside: +6.83%
Roche Holding AG
May 8, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: CHF 353.40
Upside: -3.79%
Novartis AG
Mar 6, 2026
Rated: Hold
Price Target: CHF 92.00 → CHF 110.00
Current: CHF 126.78
Upside: -13.24%
Barratt Redrow plc
Feb 11, 2026
Maintained: Hold
Price Target: 414p
Current: 295p
Upside: +40.29%
Novo Nordisk A/S
Jan 16, 2026
Maintained: Buy
Price Target: kr 400.00 → kr 415.00
Current: kr 335.80
Upside: +23.59%
GSK plc
Jan 6, 2026
Maintained: Hold
Price Target: 1,660p
Current: 1,940p
Upside: -14.43%
Sanofi
May 16, 2025
Maintained: Buy
Price Target: $63 → $67
Current: $42.89
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $55 → $60
Current: $64.86
Upside: n/a
Feb 10, 2022
Maintained: Hold
Price Target: €197.00
Current: €142.85
Upside: n/a
Jun 14, 2021
Maintained: Hold
Price Target: $43
Current: $24.91
Upside: n/a
Sep 11, 2018
Maintained: Hold
Price Target: €78.58
Current: €48.44
Upside: n/a
Sep 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $13.97
Upside: n/a